Search Results - canan+schumann

1 Results

Sort By:

Treatment for Muscle Atrophy and for Enhancing Muscle Growth

An mRNA based therapeutic that provides for increased hepatic production of follistatin Background Muscle atrophy is a detrimental and often severely debilitating disease state whose etiology lies within a myriad of disease states ranging from AIDS, sepsis, cardiac failure, muscular dystrophies, cancer, and the natural process of aging. The extent...

Published: 6/10/2024 | Inventor(s): Oleh Taratula, Canan Schumann, Olena Taratula, Adam Alani

Keywords(s): atrophy, growth, mRNA carrier, mRNA delivery, muscle, Muscular Dystrophy, wasting

Category(s): Therapeutics